Targeting AQP4 localization as a novel therapeutic target in CNS edema

CNS edema is a pathological phenomenon after trauma, infection, tumor growth, or obstruction of blood supply, and it also can be fatal or lead to long-term disability, psychiatric disorders, substance abuse, or self-harm [1,2]. One exciting possibility would be to control excessive water accumulation in cells. However, all trials that inhibit water channel protein failed in clinic. A recent study by Kitchen et al. [3] reported that targeting the astrocytes’ surface localization of water channel protein aquaporin-4 (AQP4) significantly relieves CNS edema. Astrocytes are the most abundant cell type of the brain and generally have a greater capacity than neurons to survive stresses [4]. Astrocyte cell function is critically affected by the lack of oxygen supply (hypoxia) to the brain, which is usually associated with CNS edema [5]. Their work holds new promise for our ability to use water-transfer strategies to treat CNS edema. Cytotoxic and vasogenic edema are primary interrelated etiological factors for the progress of CNS edema [6]. Vasogenic edema also depends on the extent of cytotoxic edema and the nature/severity of the underlying cause of the cytotoxic edema. So, understanding the pathogenesis of cytotoxic edema is important for the treatment of CNS edema. Aquaporins (AQPs) are historically known to be passive transporters of water. Lines of evidence in the last decade have highlighted the diverse function of AQPs beyond water homeostasis, including regulation of renal water balance, brain-fluid homeostasis, triglyceride cycling, and skin hydration [7]. Moreover, a subgroup of AQP water channels, termed ‘aquaglyceroporins’, also facilitates transmembrane diffusion of small, polar solutes not only water but also solutes [8,9]. AQP4 is the major subtype of AQPs expressed in astrocytes throughout the nervous system and facilitates astroglial cell migration via increasing plasma membrane water permeability, which in turn upregulates the transmembrane water fluxes during astroglial cell movement and is thus considered as an interesting therapeutic target in various neurological disorders. Astrocyte swellingmay also cause cytotoxic component disruptions of the blood–brain barrier, suggesting that astrocytes seem so sensitive to cytotoxic edema. AQP4 is a recognized contributor for the formation of cytotoxic brain edema, which is mainly a phenomenon of intracellular swelling of astrocytes. Knockdown of ‘AQP4’ or removal of the perivascular AQP4 pool by α-syntrophin or α-syntrophin deletion has been convincingly proven to counteract osmotically induced acute brain edema following ischemia and other brain injuries [10–12]. A previous study revealed that the NH2-cytosolic terminus of AQP4 interacts with metabotropic glutamate receptor 5 and assembles with the catalytic subunit of Na,K-ATPase to form a complex that has the potential function for the regulation of water permeability and potassium homeostasis in the astrocytes [13] (Fig. 1). In addition, AQP4 may trigger astrocytic Ca2+ responses, which is partly dependent on autocrine purinergic signaling (P2 purinergic receptor) activation in response to hypoosmotic stress [14] (Fig. 1). Additionally, subcellular relocalization of AQP4 in primary astrocytes is induced by calmodulin (CaM), calcium, and PKA in response to hypotonicity [15]. Further study proved that hypoxia-driven astrocyte swelling induces the increased abundance of AQP4 and initiates AQP4 cell-surface relocalization in a CaM- and PKA-dependent manner [3] (Fig. 1).     

Molecular evolution and expression pattern of Toll-like receptor 3 from the lamprey Lampetra japonica

Toll-like receptors(TLRs)are type I transmembrane proteins that are important components of innate immunity and play essential roles in inducing acquired immune responses[1].These proteins consist of three parts:the cytoplasmic domain,transmembrane domain,and extracellular domain.The extracellular domain is composed of 18–33 leucine-rich repeat(LRR)sequences that enable the host to specifically recognize pathogen-associated molecular patterns and are the core of TLR recognition ligands[2].The cytoplasmic domain is homologous with the interleukin 1 receptor(IL-1R)family and known as the Toll-IL-1 receptor homology domain,which is highly conserved and plays a key role in signal transduction[1].TLR3 recognizes viral dsRNA during immune protection from viruses[3].After the host is infected by a virus,the LRR region of TLR3 recognizes the viral dsRNA,and the Toll/IL-1 receptor(TIR)domain recruits the adaptor protein TIR domain-containing molecule 1(also known as TRIF)for signal cascade transmission[4].The activation of TLR3 finally leads to cytokine secretion,especially the production of type I interferon[4].Lamprey,the most primitive marine jawless vertebrate,is an ideal model for studying vertebrate embryo development,organ differentiation,and immune system evolution[5].Although jawless vertebrates contain three variable lymphocyte receptors,they have not been found to possess the recombinational antigen receptors shared by all jawed vertebrates[6].Compared with that in higher vertebrates,the mechanism of acquired immunity in lampreys is still not complete,and lampreys rely mainly on innate immunity to fight against pathogenic microorganisms.Although TLR3 has been extensively studied in jawed vertebrates,little is known about the molecular evolutionary history and expression patterns of TLR3 in jawless vertebrates.     

Norepinephrine transporter（NET）is expressed in cardiac sympathetic ganglia of adult rat

INTRODUCTIONThe sympathetic nervous system (SNS) plays animportant role in regulating cardiac function in bothhealth and disease through releasing neurotransmit-ter norepinephrine (NE). 1n central nervous sys-tem (CNS), the neurotransmission of NE is terminated tbIough reuptaxe of released neurotransndt-ter by Na , Cl---dependent norepineplirine trans-porter (NET) on pre--synaPtic membrane[1, 2]. ALthough the NE uptake was well studied in heaxt, butthe molecular basis fOr that is s…     

Dying T lymphocytes call for the death of tumor cells

Immunotherapy that specifically targets tumor cells is the preferred approach to induce tumor regression.Over the pastdecade,significant progress has been made in devising various methods to direct the immune system to respond to tumorcells.The major hurdle for successful immunotherapy is to overcome immune tolerance in the tumor microenvironment.Recent clinical trials with dendritic cell-based vaccination[1,2]and CTLA4 blocking antibodies[3]have shown greatpromise,though complete cancer regression is not always achieved[4].Currently,alternative strategies potentially leadingto cancer eradication or regression in animal or clinical models are being enthusiastically pursued.In this issue of CellResearch,Wang et al.report a novel way to induce tumor immunity by the use of irradiated autologous T cells[5].     

Epitranscriptomics: Toward A Better Understanding of RNA Modifications

<正>Ever since the first RNA nucleoside modification was characterized in 1957~[1],over 100 distinct chemical modifications have been identified in RNA to date~[2].Most of these modifications were characterized in non-coding RNAs(nc RNAs),including t RNA,r RNA,and small nuclear RNA(sn RNA)~[3].Studies in the past few decades have located various modifications in these nc RNAs and revealed their functional roles~[3].For instance,N1-methyladenosine(m~1A),which is typically     

Altered expression of nuclear matrix proteins in etoposide induced apoptosis in HL－60 cells

INTRODUCTIIONThe nuclear matrix is an essential component ofthe nucleus which is important for the nuclear structural integrity and specific genomic functions[1, 2].Several articles have reported that the nuclear matrix, as a higher order framework structures, mightbe disassembled du-ring the apoptotic process[3-5].Accordingly3 nuclear lamins A/C or B have beenfound to decrease in apoptotic thymocytes[6], Tcells[7], and carcinoma cell line[8, 9]. The nucleolar protein B23, an obscure ma…     

Raloxifene hydrochloride treatment leads to better outcomes than medroxyprogesterone acetate when paired with estrogen in ovariectomized cholesterol-fed rabbits

The benefits of estrogen in cardiovascular system include a reduction in low-density lipoprotein cholesterol （LDL-C）, decrease in LDL oxidation, and enhancement of vascular function [1]. Estrogen replacement therapy, however, has been linked to an increased risk of tissue-specific side effects including breast cancer and uterine cancer [2]. These issues have led to the development of hormone replacement therapy （HRT） which combines estrogen and progestin. Progestin can reverse endometrial hyperplasia induced by estrogen. The most commonly used progestin in HRT is medroxyprogesterone acetate （MPA）, a synthetic progestin, although there is some evidence that the administration of MPA is not as beneficial as natural progesterone [3]. Findings from randomized placebo-controlled trials have demonstrated that the combination of estrogen and MPA does not confer cardiac protection and may increase the risk of coronary heart disease among healthy postmenopausal women, especially in the first year after initiation of hormone therapy. Furthermore, an increase in the risk of breast cancer was also found with this therapy [4]. Although the role of progestin remains poorly defined, it is possible that the coadministration of progestin could counteract the cardioprotective effects of estrogen .     

GABA transporter 1 transcriptional starting site exhibiting tissue specific difference

INTRODUCTIONIn the vertebrate central nervous system (CNS),GABA transporters (GAT) are believed to play animportant role in termination of GABAergiC transInission. GATI was the first cloned member of neurotransmitter transporters superfanilly[1], and soon,other three subtypes (GAT2-4) were subsequentlycloned. Since GABA is the predominant inhibitoryneurotranslliltter in CNS, abnormallty of GATs hasa direct relationship with certain kinds of nervousdisorders, such as epilepsy a…     

Comparative analysis of the pig BAC sequence involved in the regulation of myostatin gene

Myostatin (GDF-8, MSTN) is a member of trans- forming growth factors (TGF-β) superfamily, which was first described by McPherron et al. in 1997[1]. Myostatin appears to act as a negative regulator of muscle development and controls not only fibre size but also fibre number[2,3]. Mutations in the third exon of the myostatin gene have been shown to cause dou- ble muscling in cattle[4]. By knocking out the gene of myostatin in mice, they were able to show that the transgenic mice developed …     

Alteration of β-secretase traffic by the receptor tyrosine kinase signaling pathway- a new mechanism for regulating Alzheimer's β-amyloid production

The receptor tyrosine kinases (RTKs) are a family of cellsurface proteins with diverse functions in proliferation, dif-ferentiation or cell-cell communication. When a specific li-gand binds to its cognate receptor, a conformational changeof this receptor due to the ligand-receptor interaction willlead to activation of the intrinsic tyrosine kinase residing inthe intracellular domain of the receptor. The activation ofthis tyrosine kinase is essential for transducing the signals toa cascade of its downstream molecules that eventually causerelated physiological responses [1]. For example, binding ofnerve growth factor (NGF) to its receptor TrkA is essentialfor the proper development, patterning, and maintenanceof the mammalian nervous system. This ligand and recep-tor interaction will lead to the formation of a crab-shapedhomodimeric TrkA structure [2], and the subsequent activa-tion of its intrinsic RTK will cause auto-phosphorylationof its own intracellular tyrosine residues. PhosphorylatedTrkA receptors recruit and increase the phosphorylationof PLC-γ and Shc, which leads to activation of either thePI3K/Akt pathway or Ras/raf/ERK pathway. In the brainOf Alzheimer's disease (AD) patients, alterations of nervegrowth factor (NGF) and its receptor TrkA have beenreported to associate with AD pathogenesis [3]. However,the underlying mechanisms remain elusive.     

Preparation of recombinant human canstatin using transgenic Dunaliella safina

Canstatin, which possesses a significant inhibition effect on the migration of endothelial cells and a strong anticancer effect [1,2], has been applied in the treatment of many cancers including human oral, breast, prostate, pancreatic, and colorectal [3-7]. However, because the expression of bioactive recombinant canstatin is very low using the current expression systems, e.g. prokaryotic Escherichia coli expression system [6], its application has still been limited to clinical trials. Several eukaryotic cell expression systems have been exploited for canstatin production, such as Bombyx mori cells [8] and Drosophila melanogaster S2 cells [9], but they also have a lot of disadvantages, for example, high culture cost, poor yield, and difficulty in purification. Therefore, it is necessary and urgent to develop an optimal expression system for the large-scale production of the recombinant canstatin.     

Signal Peptide of Potato PinII Enhances the Expression of Cry1Ac in Transgenic Tobacco

Insect-resistant plants have been developed throughexpression of insecticidal proteins from Bacillusthuringiensis (Bt) in the early 1980s [1,2]. However, forcontrol of insect pests, it is necessary to increase theexpression of Bt protein overall or in specific plant tissues.To increase the expression level, synthetic Bt genes havebeen developed and used to produce transgenic plants[2–5]. A number of approaches have been taken to increasethe expression level of foreign proteins in transgeni…     

Chicken retinal ganglion cells response characteristics: multi-channel electrode recording study

A fundamental question in neuroscience is how the information relevant to behavior is presented in the activity of neurons[1]. The visual system, especially the retina, offers some advantage to explore the neural code owing to its explicitly layered structure and relatively simple neuron types[2]. However, most of what we know about retinal signaling is derived from single neuron recordings[2,3]. The assumptions underlying this approach are that individual neuron acts as a unique element dedi…     

A model of a human heart via graph nano topological spaces

In this paper,new forms of nano topological spaces through a neighborhood system of vertices for a digraph will be presented and studied.We apply the connection between digraph theory and nano topological spaces in the human heart as an example in real life.We have a blood flow system in the human heart with respect to oxygenated and deoxygenated blood circulation.Our study will be definitely helpful to develop a tool in solving the blood flow system in the human heart.Finally,we have succeeded in improving Proposition 1.6 in [7] and Proposition 4.4.1 in [11].     

Nor1, a novel cytokine-responsive regulator of pancreatic β-cell mass and function mediated by disruption of mitochondrial networks

Type 2 diabetes(T2D)is a chronic metabolic disease characterized by insulin resistance and hyperglycemia,which is ultimately linked to the loss of pancreaticβ-cells and their function[1].Understanding the pathological mechanisms ofβ-cell dysfunction in T2D may lead to development of new therapeutic approaches.Recently,compelling evidence suggests that members of the nuclear receptor 4A(NR4A)subgroup play a pivotal role inβ-cell loss[2].Nor1,also known as NR4A3,belongs to the NR4A subfamily,which also includes Nur77(NR4A1)and Nurr1(NR4A2),and is defined as a true orphan nuclear receptor with an unknown endogenous ligand or ligand independent[3].As a regulator of gene expression located in the nucleus,Nor1 exhibits tissue-specific expression,which selectively controls diverse biological processes,including cell proliferation,apoptosis,differentiation,immune homeostasis,and fuel utilization[4].Thus far,it was reported that Nor1 is involved in numerous pathologies such as cancer,inflammatory diseases,and Parkinson’s disease[4].     

PRMT2β suppresses autophagy and glycolysis pathway in human breast cancer MCF-7 cell lines

Autophagy as a novel therapeutic target can inhibit or increase treatment efficacy in various types of breast cancer in a cell-type-dependent manner [1,2].Several studies have revealed that the coordination between Akt and the glycolytic pathway plays an indispensable role in mediating autophagy and caspase-dependent apoptosis,suggesting that a new regulatory mechanism for the process [3,4].Protein arginine N-methyltransferases(PRMTs)are eukaryotic enzymes that catalyze the transfer of methyl groups from S-adenosylmethionine to arginine residues of numerous PRMT substrates [5,6].PRMT2(also known as HRMT1L1)belongs to the arginine methyltransferase family [7].PRMT2β is a novel PRMT2 splice variant isolated from breast cancer cell [8].It occurs at the 3′ end of the PRMT2,resulting in loss of exons 7–9 and downstream frame-shifting [9].PRMT2β possesses 83 new amino acids at the C-terminus and its size is 301 amino acids.Our previous study reported that PRMT2β has potential antitumor effect by suppressing cyclin D1 expression [10].However,little is known about whether PRMT2β could regulate autophagy and glycolysis of MCF-7 cells.     

129S2/SvPasCrl小鼠肠道在衰老过程中的变化

Dear Editor:We would like to show"changes in intestinal lengths of 129 S2/SvPasCrl mice from adulthood to agedness".The intestine functions not only in digestion,absorption and excretion,but also in the regulation of central nervous system through its microbiota so as called gut-brain axis[1].As a tubular organ,the intestinal length is regarded as a significant morphological characteristic,which directly affects digestion and absorption[2].Thus,clarifying changes in intestinal lengths at different ages is beneficial to understand the functions of the digestive system as well as the aging process.